Cashu FinanceCashu Finance
  • Terminal
  • Pulse
  • Spotlight
  • News
  • Cashu Research
Log inSign Up
← Back to Terminal
  1. Stocks
  2. Healthcare
  3. OTC
  4. BAYRY

Market Cap: $60.32B

BA

Bayer AG

BAYRY
OTC (Other OTC)USD
Invest in BAYRY
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutive
Cashu FinanceCashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksScreenersAboutAuthorsAdvertisersBrokersConferencesContact

Legal

Terms of ServicePrivacy PolicyEditorial PolicyCorrections Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

Executive

William N. Anderson

Chairman of the Management Board & Chief Executive Officer

Compensation
€6,331,595
Julio Triana

Member of Management Board & President of Consumer Health Division

Compensation
€2,352,912
Rodrigo Santos

Member of Management Board, Head of the Crop Science Division & President of Crop Science Division

Compensation
€2,563,644
Judith Hartmann

Chief Financial Officer & Member of Management Board

Compensation
€2,601,113
Wolfgang U. Nickl

Chief Financial Officer & Member of Management Board

Compensation
€2,601,113
Alex Buschermohle

Chief Information Officer, Head-Digital Transformation & IT-Crop Science Division

Compensation
Compensation not disclosed
Bill Dodero

General Counsel and Senior Vice President of Law Patents & Compliance

Compensation
Compensation not disclosed
Daniella Foster

SVP and Global Head of Public Affairs,Science & Sustainability for Bayer's Consumer Health Division

Compensation
Compensation not disclosed
Heike Prinz

Chief Talent Officer, Labor Director & Member of Management Board

Compensation
€2,675,986
Jana Marlen Ackermann

Head of the Investor Relations

Compensation
Compensation not disclosed
Jost Reinhard

President of the Radiology Business for Pharmaceuticals Division

Compensation
Compensation not disclosed
Michael Preuss

Head of Communications, Government Relations and Corporate Brand

Compensation
Compensation not disclosed
Stefan Oelrich

President of the Pharmaceuticals Division & Member of the Board of Management

Compensation
€2,479,388